Tony J. Wu, PhD, is the senior partnership manager for AACR Project GENIE. Wu joined the AACR to establish the business development vertical for Project GENIE and spearhead strategic engagement with biopharma, regulatory, and academic partners. Before joining AACR, Wu founded Zygosity Ltd, a University of Cambridge spin-out backed by venture capital, to develop innovative CRISPR-based cellular and genetic medicines by applying machine learning to the principles of gene engineering. This venture was an extension of his previous work with Cancer Research UK where he scouted assets and performed due diligence to identify and accelerate the translation of scientific breakthroughs for both clinical and commercial benefit. Having spent time as a bench scientist and laboratory manager at the University of Chicago and University of Pennsylvania, Wu is a classically trained cancer biologist. In these roles, he provided oversight of federal, charity and private research funding to drive efficient project management and laboratory operations. Wu earned a double BA in psychology and human biology from the University of Kansas, an MA in social economics from the University of Pennsylvania, and a PhD in cancer immunology from the University of Cambridge.